Katie Marceau

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

Hani M. Babiker, Sara A. Byron, William P.D. Hendricks et al. · Investigational New Drugs · 2018 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II pilot trial of nivolumab (N) + albumin bound paclitaxel (AP) + paricalcitol (P) + cisplatin (C) + gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC).

Erkut Borazanci, Gayle Jameson, Mitesh J. Borad et al. · Journal of Clinical Oncology · 2018 · 21 citations

Medicine, Oncology, Pharmacology +17

Abstract CT224: Pilot study in patients with advanced solid tumors to evaluate feasibility of ferumoxytol (FMX) as tumor imaging agent prior to MM-398, a nanoliposomal irinotecan (nal-IRI)

Ramesh K. Ramanathan, Ronald L. Korn, Jasgit C. Sachdev et al. · Cancer Research · 2014 · 17 citations

Medicine, Oncology, Pharmacology +17